7-Bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

Catalog No. :
ACPYVQ520
CAS No. :
1564451-53-1
Molecular Formula :
C9H7BrFNO2
Molecular Weight :
260.06

IUPAC Name:7-bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

7-Bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$225.00Login to see priceInquiryInquiry
100mg97%$328.00Login to see priceInquiryInquiry
250mg97%$459.00Login to see priceInquiryInquiry
1g97%$909.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
IUPAC Name7-bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
MDL No.MFCD26900587
Molecular FormulaC9H7BrFNO2
Molecular Weight260.06
SMILESO=C1NCCOC2=CC(F)=C(Br)C=C12
InChI KeyFDLCCMFQVJTURC-UHFFFAOYSA-N
Synonym7-bromo-8-fluoro-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one;7-Bromo-8-fluoro-3,4-dihydro-1,4-benzoxazepin-5(2H)-one;1,4-Benzoxazepin-5(2H)-one, 7-bromo-8-fluoro-3,4-dihydro-;7-Bromo-8-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one
CAS No.1564451-53-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPYVQ520 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYVQ520 route product structure diagram
    ACPYVQ5201564451-53-1
Inquiry

2. ACPYVQ520 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYVQ520 route product structure diagram
    ACPYVQ5201564451-53-1
Inquiry

Comments (0)